These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 6610689)

  • 21. Autoantibodies to small nuclear ribonucleoproteins. A strong association between anti-SS-B(La), HLA-B8, and Sjögren's syndrome.
    Whittingham S; Mackay IR; Tait BD
    Aust N Z J Med; 1983 Dec; 13(6):565-70. PubMed ID: 6609699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patterns of clinical disease associated with antibodies to nuclear ribonucleoprotein.
    Maddison PJ; Mogavero H; Reichlin M
    J Rheumatol; 1978; 5(4):407-11. PubMed ID: 310884
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autoantibodies to the A/B proteins of the heterogeneous nuclear ribonucleoprotein complex: novel tools for the diagnosis of rheumatic diseases.
    Steiner G; Skriner K; Smolen JS
    Int Arch Allergy Immunol; 1996 Dec; 111(4):314-9. PubMed ID: 8957102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibodies against distinct nuclear matrix proteins are characteristic for mixed connective tissue disease.
    Habets WJ; de Rooij DJ; Salden MH; Verhagen AP; van Eekelen CA; van de Putte LB; van Venrooij WJ
    Clin Exp Immunol; 1983 Oct; 54(1):265-76. PubMed ID: 6352106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical value of an integrated ELISA system for the detection of 6 autoantibodies (ssDNA, dsDNA, Sm, RNP/Sm, SSA, and SSB).
    Froelich CJ; Wallman J; Skosey JL; Teodorescu M
    J Rheumatol; 1990 Feb; 17(2):192-200. PubMed ID: 2108246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical features of patients with antibodies directed against proliferating cell nuclear antigen.
    Fritzler MJ; McCarty GA; Ryan JP; Kinsella TD
    Arthritis Rheum; 1983 Feb; 26(2):140-5. PubMed ID: 6600614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The purification, characterization and amino acid analysis of nuclear ribonuclear protein and Sm antigens reacting with human autoimmune sera.
    Fritzler MJ; O'Brien MD
    Clin Invest Med; 1983; 6(2):61-71. PubMed ID: 6883833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autoantibody profiles in canine ANA-positive sera investigated by immunoblot and ELISA.
    Welin Henriksson E; Hansson H; Karlsson-Parra A; Pettersson I
    Vet Immunol Immunopathol; 1998 Feb; 61(2-4):157-70. PubMed ID: 9613431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibodies to antinuclear subsets in systemic lupus erythematosus and rheumatoid arthritis.
    Smolen JS; Hassfeld W; Graninger W; Steiner G
    Clin Exp Rheumatol; 1990; 8 Suppl 5():41-4. PubMed ID: 2245525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoantibodies to nuclear antigens (ANA): their immunobiology and medicine.
    Tan EM
    Adv Immunol; 1982; 33():167-240. PubMed ID: 6182766
    [No Abstract]   [Full Text] [Related]  

  • 31. Anti-A2/RA33 autoantibodies are directed to the RNA binding region of the A2 protein of the heterogeneous nuclear ribonucleoprotein complex. Differential epitope recognition in rheumatoid arthritis, systemic lupus erythematosus, and mixed connective tissue disease.
    Skriner K; Sommergruber WH; Tremmel V; Fischer I; Barta A; Smolen JS; Steiner G
    J Clin Invest; 1997 Jul; 100(1):127-35. PubMed ID: 9202064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of autoantibodies to recombinant (U1) RNP-associated 70K antigen in systemic lupus erythematosus.
    St Clair EW; Query CC; Bentley R; Keene JD; Polisson RP; Allen NB; Caldwell DS; Rice JR; Cox C; Pisetsky DS
    Clin Immunol Immunopathol; 1990 Feb; 54(2):266-80. PubMed ID: 2104788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AUF1, the regulator of tumor necrosis factor alpha messenger RNA decay, is targeted by autoantibodies of patients with systemic rheumatic diseases.
    Skriner K; Hueber W; Süleymanoglu E; Höfler E; Krenn V; Smolen J; Steiner G
    Arthritis Rheum; 2008 Feb; 58(2):511-20. PubMed ID: 18240226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibodies to Sm, RNP and SSB detected by solid-phase ELISAs using recombinant antigens: a comparison study with counter immunoelectrophoresis and immunoblotting.
    Delpech A; Gilbert D; Daliphard S; Le Loet X; Godin M; Tron F
    J Clin Lab Anal; 1993; 7(4):197-202. PubMed ID: 8360794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of immunoblotting and immunoprecipitation of (U) small nuclear ribonucleoproteins in the analysis of sera of patients with mixed connective tissue disease and systemic lupus erythematosus. A cross-sectional, longitudinal study.
    Pettersson I; Wang G; Smith EI; Wigzell H; Hedfors E; Horn J; Sharp GC
    Arthritis Rheum; 1986 Aug; 29(8):986-96. PubMed ID: 3488746
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-RNP monoclonal antibodies derived from a mouse strain with lupus-like autoimmunity.
    Billings PB; Allen RW; Jensen FC; Hoch SO
    J Immunol; 1982 Mar; 128(3):1176-80. PubMed ID: 6173424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of human T cell and B cell responses against U small nuclear ribonucleoprotein 70-kd, B, and D polypeptides among patients with systemic lupus erythematosus and mixed connective tissue disease.
    Holyst MM; Hill DL; Hoch SO; Hoffman RW
    Arthritis Rheum; 1997 Aug; 40(8):1493-503. PubMed ID: 9259431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-RNP antibodies and their clinical significance.
    Montecucco C
    Br J Rheumatol; 1990 Oct; 29(5):322-4. PubMed ID: 2224398
    [No Abstract]   [Full Text] [Related]  

  • 39. Antibodies to hnRNP core protein A1 in connective tissue diseases.
    Astaldi Ricotti GC; Bestagno M; Cerino A; Negri C; Caporali R; Cobianchi F; Longhi M; Maurizio Montecucco C
    J Cell Biochem; 1989 May; 40(1):43-7. PubMed ID: 2745573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibodies against extractable nuclear antigens (ENA) in systemic scleroderma.
    Jabłońska S; Błaszczyk M; Górkiewicz A; Jarzabek-Chorzelska M; Rzesa G; Chorzelski T
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):765-8. PubMed ID: 312085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.